The stock was sold at an average price of $64.18 per share, for a total transaction price of $1.54 million. Ms. Gulmi now owns 118,057 company shares, which are valued at approximately $7.58 million.
AmSurg has a one-year low of $40 and a one-year high of $65.03, according to the report.
More articles on transactions and valuation issues:
Surgery Partners prepares to file IPO
5 things to know about North Carolina’s CON reform bill
Study questions the efficacy of CON programs
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
